Why Summit Therapeutics Inc. (SMMT) Crashed On Wednesday
We recently published a list of Investors Are Dumping These 10 Stocks.
Posts Tagged ‘NASDAQ:SMMT’
Why Summit Therapeutics Inc. (SMMT) Skyrocketed On Tuesday
We recently published a list of 10 Stocks Leaving Wall Street in The Dust.
Truist Sticks to $35 Target on Summit (SMMT) Despite Shifting Deal Landscape
In a June 2 report, Truist Securities analyst Asthika Goonewardene weighed in on the implications of Bristol-Myers Squibb’s newly announced partnership with BioNTech SE on Summit...
Why Summit Therapeutics Inc. (SMMT) Crashed Last Week
We recently published a list of These 10 Stocks Just Rocked The Market. In this article, we are going to take a look at where Summit Therapeutics Inc.
Why Summit Therapeutics Inc. (SMMT) Crashed On Friday
We recently published a list of These 10 Stocks Lost This Much Today.
Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal
Bernstein analysts reaffirmed their Market Perform rating and $30 price target for Pfizer Inc.
10 Best Cancer Stocks to Invest in for Long-Term Gains
After cardiovascular disease, cancer is the second most common cause of mortality worldwide.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2025 Earnings Call Transcript
Operator: Thank you for standing by. Hello and welcome to the Summit Therapeutics Q1 2025 Earnings Conference Call.
12 Best Multibagger Stocks to Buy in 2025
In the world of investing, the term "multibagger" refers to stocks that have the potential to deliver returns several times greater than the original investment.
10 Hot Growth Stocks to Invest in According to Analysts
The big rally in the broader stock market might have ceased, but there are a lot of things to focus on under the surface, says Morningstar.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2024 Earnings Call Transcript
Operator: Good morning and welcome to Summit Therapeutics Fourth Quarter and Year End 2024 Earnings and Update Call.
15 Stocks That Will Go to The Moon According to Analysts
While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President ...
12 Best Growth Stocks to Invest In According to Analysts
Companies experiencing above-average earnings growth, which is often fueled by innovations and market expansions, are known as growth stocks.
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
Jim Cramer Recently Looked Into These 8 Stocks
Jim Cramer, the host of Mad Money, took to the airwaves last Friday to discuss the recent stir caused by DeepSeek in the tech world.
10 Unstoppable Stocks to Buy in 2025
As per the recent earnings update by FactSet dated 24th January 2025, the Q4 2024 earnings season for the S&P 500 has seen a strong start.
Why These 15 Stocks Are Skyrocketing in 2025
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.
12 Hot Stocks to Buy According to Analysts
While the stock market in the United States remained closed on January 20 for Martin Luther King, Jr.
10 Best Russell 2000 Stocks to Invest in According to Analysts
The Russell 2000 Index is a widely followed benchmark that tracks the performance of small-cap companies in the United States.
12 Best Multibagger Stocks to Buy Right Now
The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs.
10 Best Performing Biotech Stocks in 2024
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
Summit Therapeutics (SMMT) Hurt Bronte Capital. Here’s Why
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2024 Earnings Call Transcript
Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2024 Earnings Call Transcript October 30, 2024Summit Therapeutics Inc. misses on earnings expectations.
8 Unstoppable Stocks That Could Make You Richer
In the current climate of extreme market volatility, finding safe and stable investments is challenging.
10 Best QQQ Stocks to Buy According to Analysts
Several recent discussions have focused solely on the implications of the Fed's recent rate cut for the market.
10 Best Performing NASDAQ Stocks in 2024
Fed's recent cut has resulted in significant outperformance in the tech sector, signaling a positive sentiment among investors.
7 Best High Short Interest Stocks To Invest In
China's housing market, once a booming sector, has experienced a significant downturn in recent years.
10 Best Performing Stocks in 2024
The Dow Jones Industrial Average has recently made headlines by closing above the 42,000 mark for the first time, a significant milestone that reflects a surge in investor confidence...
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06.
Insiders Are Buying These 11 Penny Stocks
In this article, we will take a detailed look at Insiders Are Buying These 11 Penny Stocks. For a quick overview of such stocks, read our article Insiders Are Buying These 5...
Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2023 Earnings Call Transcript
Operator: Good morning and welcome to Summit's Fourth Quarter and Year End 2023 Earnings Call. [Operator Instructions] Please refer to the company's website for updates.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.
25 Biggest Stocks with Negative Beta
Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q2 2023 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Summit Therapeutics Second Quarter 2023 Earnings Call. Please note that this call is being recorded.
11 Stocks with Heavy Insider Buying in 2023
Insider trading activity has always invited interest and controversy from investors and authorities.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Summit Therapeutics First Quarter 2023 Earnings and Update Call. [Operator Instructions].
10 Best Stocks to Buy for a Quick Return
The stock market is made up of thousands of stocks, belonging to a wide variety of industries and sectors.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Brent, and I will be your conference operator today.
5 Penny Stocks with Insider Buying
Franklin Street Properties Corp. (NYSE:FSP) is a real estate investment trust (REIT) that is headquartered in Wakefield, Massachusetts.
10 Best Penny Stocks to Buy in September
In this article, we will take a look at the 10 best penny stocks to buy in September.
Is Summit Therapeutics PLC (SMMT) A Good Stock To Buy?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
13D Filing: Lansdowne Partners and Summit Therapeutics PLC (ADR) (SMMT)
Please follow Lansdowne Partners (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Lansdowne Partners or update its stock holdings...
Market Movers Today: Iovance Biotherapeutics Inc (IOVA), Key Technology, Inc. (KTEC), Union Pacific Corporation (UNP), and More
What happened: Shares of pre-revenue biopharma Iovance Biotherapeutics (NASDAQ:IOVA) rose nearly 30% today after the company announced preliminary results from two phase 2 trials...
13D Filing: Lansdowne Partners and Summit Therapeutics PLC (ADR) (SMMT)
Please follow Lansdowne Partners (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Lansdowne Partners or update its stock holdings...
What We’re Looking For From Summit Therapeutics PLC (ADR) (SMMT)
Summit Therapeutics PLC (ADR) (NASDAQ:SMMT) is running up this week on an update relating to its lead C. Difficile infection asset, Ridinilazole.
Delta Air Lines Inc. (DAL), Summit Therapeutics PLC (ADR) (SMMT) & More: A Look at Five Stocks on the Move Today
Markets have opened at shaky note with major indices treading on margin.
Summit Therapeutics PLC (ADR) (SMMT) Is Hot On Sarepta Therapeutics Inc (SRPT)’s DMD Tail
Duchenne’s Muscular Dystrophy (DMD) is a hot topic right now.
Hedge Fund Sentiment Is Stagnant On Summit Therapeutics PLC (ADR) (SMMT)
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies.
